The Influence of Rehabilitation Characteristics in the Incidence of Peri-Implant Pathology: A Case-Control Study

被引:7
作者
de Araujo Nobre, Miguel Alexandre [1 ,2 ]
Malo, Paulo [2 ]
机构
[1] Univ Lisbon, Fac Med, Prevent Med Unit, P-1699 Lisbon, Portugal
[2] Malo Clin, P-1600042 Lisbon, Portugal
来源
JOURNAL OF PROSTHODONTICS-IMPLANT ESTHETIC AND RECONSTRUCTIVE DENTISTRY | 2014年 / 23卷 / 01期
关键词
Peri-implant pathology; dental implants; rehabilitation characteristics; OSSEOINTEGRATED TITANIUM FIXTURES; MARGINAL TISSUE-REACTIONS; BACTERIAL-COLONIZATION; COMPLICATION RATES; SURFACE-TOPOGRAPHY; PLAQUE RETENTION; DENTAL IMPLANTS; ORAL IMPLANTS; SURVIVAL; PART;
D O I
10.1111/jopr.12114
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
PurposeTo investigate the influence of rehabilitation characteristics in the incidence of peri-implant pathology (P-iP). Materials and MethodsA total of 1350 patients (270 with P-iP matched for age, gender, and time of follow-up with 1080 controls without P-iP) rehabilitated with dental implants were included. The effect of the independent variables [Implant length in millimeters (IL); implant diameter in millimeters; implant surface (IS); presence of cantilevers; implant:crown ratio (ICR), type of abutment (TA); abutment height; fracture of prosthetic components (FPCs); type of prosthetic reconstruction (TPR); type of material used in the prosthesis (TMUP); loosening of prosthetic components (LPCs); and passive misfit (PM) diagnosed within the previous year] was evaluated through bivariate analysis (chi-square), with level of significance of 5%. Crude odds ratios (OR) with 95% confidence intervals and the attributable fraction (AF) were calculated for the independent variables individually identified as factors associated with the incidence of peri-implant pathology. ResultsThe following variables were identified as risk factors: machined IS (p = 0.015; OR = 1.46), 17 degrees TA (p = 0.000; OR = 3.06), completely edentulous TPR (p = 0.000; OR = 2.49), TMUP (p = 0.000; metal-acrylic OR = 2.29; acrylic OR = 4.90; metal-ceramic OR = 8.43), 1:1 ICR (p = 0.002; OR = 1.54), FPC (p = 0.000; OR = 3.01), LPC (p = 0.000; OR = 4.15), and PM (p = 0.002; OR = 20.36). The attributable fraction rendered the following theoretical potential reductions in the cases if the exposure to the variables was removed: IS (31.5%), TA (67.3%), TMUP (5.4% to 73.3%), ICR (35%), FPC (66.8%), LPC (73.8%), and PM (95.1%). ConclusionsWithin the limitations of this study, machined implant surfaces, 17 degrees abutments, completely edentulous reconstructions, the type of metal used in the prosthesis, 1:1 implant:crown ratio, fracture of prosthetic components, loosening of prosthetic components, and passive misfit emerged as risk factors for the incidence of P-iP. Eliminating the exposure to these variables would, in theory, result in a significant reduction in the incidence of P-iP.
引用
收藏
页码:21 / 30
页数:10
相关论文
共 85 条
[21]   Biological factors contributing to failures of osseointegrated oral implants (I). Success criteria and epidemiology [J].
Esposito, M ;
Hirsch, JM ;
Lekholm, U ;
Thomsen, P .
EUROPEAN JOURNAL OF ORAL SCIENCES, 1998, 106 (01) :527-551
[22]  
Esposito M, 2005, COCHRANE DATABASE SY, V25
[23]   Prevalence and risk variables for peri-implant disease in Brazilian subjects [J].
Ferreira, S. D. ;
Silva, G. L. M. ;
Cortelli, J. R. ;
Costa, J. E. ;
Costa, F. O. .
JOURNAL OF CLINICAL PERIODONTOLOGY, 2006, 33 (12) :929-935
[24]  
Fiorellini JP, 2000, PERIODONTOL, V4, P98
[25]  
FRIBERG B, 1991, International Journal of Oral and Maxillofacial Implants, V6, P142
[26]  
GRACIS S E, 1991, International Journal of Prosthodontics, V4, P282
[27]  
Gunne J, 1994, Int J Prosthodont, V7, P143
[28]   The relationship of smoking on peri-implant tissue: A retrospective study [J].
Haas, R ;
Haimbock, W ;
Mailath, G ;
Watzek, G .
JOURNAL OF PROSTHETIC DENTISTRY, 1996, 76 (06) :592-596
[29]   Bone formation at titanium porous oxide (TiUnite™) oral implants in type IV bone [J].
Huang, YH ;
Xiropaidis, AV ;
Sorensen, RG ;
Albandar, JM ;
Hall, J ;
Wikesjö, UME .
CLINICAL ORAL IMPLANTS RESEARCH, 2005, 16 (01) :105-111
[30]  
Ivanoff CJ, 2003, INT J ORAL MAX IMPL, V18, P341